Archives
-
Dasatinib (BMS-354825): Assay Design Guide
2026-09-12
Dasatinib (BMS-354825) is a powerful Src and Bcr-Abl research tool, but its value depends on separating direct kinase effects from downstream phenotypes. This guide connects kinase pharmacology with the SNAI1–PIK3R2/p-EphA2 findings in thymic tumors to improve assay design and interpretation.
-
Triamcinolone: Practical Research Workflow Guide
2026-09-11
Triamcinolone B1859 provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid signaling, inflammation, and immunosuppression. This dossier-based guide covers stock preparation, storage, assay controls, and troubleshooting; the compound is for scientific research only and not for diagnostic, clinical, or therapeutic use.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-11
Use dual fluorescence to distinguish mRNA uptake from productive EGFP expression in nanoparticle, macrophage, and quantitative transfection studies. This workflow combines Cap1 chemistry, 5-moUTP modification, and direct Cy5 tracking to make delivery-system optimization more interpretable.
-
Triamcinolone: Practical Research Workflow Guide
2026-09-10
This dossier-based guide explains how to use Triamcinolone as a defined synthetic glucocorticoid agonist in glucocorticoid signaling, inflammation, and immunosuppression workflows. It addresses solubility, storage, controls, and QC while excluding clinical, diagnostic, and therapeutic use and avoiding unsupported potency or efficacy claims.
-
Triamcinolone: Practical Research Workflow Guide
2026-09-10
Triamcinolone (SKU B1859) provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. It is intended for scientific research workflows only and should not be used for diagnostic, clinical, or medical applications.
-
Cleavage-Resistant TREM2 Restores Macrophage Efferocytosis
2026-09-09
Dong et al. engineered a cleavage-resistant TREM2 receptor that preserves ligand sensing and strengthens DAP12-dependent signaling despite inflammatory ADAM17 activity. Delivered as mRNA in phosphatidylserine-functionalized lipid nanoparticles, the receptor generated macrophages in situ that improved apoptotic-cell clearance and reduced inflammation in mouse models of MASH and atherosclerosis.
-
Diclofenac in Human Intestinal Organoid Translation
2026-09-09
A translational framework for using Diclofenac as a non-selective COX inhibitor in human intestinal organoid models, connecting prostaglandin biology with absorption, metabolism, transporter activity, and assay strategy.
-
PLGA Microspheres for Controlled Cartilage Corticosteroids
2026-09-08
The 2026 reference study shows that PLGA microsphere size, surface chemistry, and drug stability jointly determine corticosteroid transport through articular cartilage. Its combination of bovine cartilage diffusion testing, HPLC-based release analysis, and ester-hydrolysis monitoring provides a practical framework for designing longer-acting intra-articular delivery systems.
-
Methylprednisolone Workflows for Inflammation and Bone
2026-09-08
Build reproducible Methylprednisolone experiments that connect glucocorticoid receptor signaling with cytokine, chemokine, and bone-loss readouts. This workflow combines practical formulation guidance with a rat osteonecrosis model to support both in vitro anti-inflammatory assays and translational study design.
-
Phosphatase Inhibitor Cocktail 1: Workflow Guide
2026-09-07
Build more reliable phosphorylation assays by adding a 100X DMSO-based inhibitor at the point of lysis and maintaining inhibition through downstream processing. This guide connects practical sample handling with the HCMV–AKT signaling study, showing how preserved phosphorylation states can sharpen mechanistic interpretation without confusing preservation with pathway activation.
-
Pazopanib and ATRX: A Translational RTK Strategy
2026-09-07
ATRX deficiency may define a therapeutically actionable vulnerability to multi-targeted RTK and PDGFR inhibition in high-grade glioma. This thought-leadership analysis positions Pazopanib (GW-786034) as a mechanistically aligned research probe while separating evidence from hypothesis and outlining a rigorous path from kinase pharmacology to biomarker-led translation.
-
Phosphatase Inhibitor Cocktail 1: Assay Logic
2026-09-05
Phosphatase Inhibitor Cocktail 1 supports protein phosphorylation preservation by protecting samples during lysis and analysis. This guide connects inhibitor selection with phosphoproteomic analysis, signaling biology, and practical assay controls.
-
ARID1A Loss and Osimertinib Resistance in Lung Cancer
2026-09-04
The reference study identifies an ARID1A–PTEN–Akt signaling axis that links chromatin regulation to acquired osimertinib resistance in lung adenocarcinoma. Its paired loss- and gain-of-function experiments suggest that restoring PTEN activity or targeting downstream Akt signaling may help explain, and potentially counter, the resistant phenotype, although validation beyond the tested cellular models is needed.
-
ERADECs Hijack ERAD to Degrade Membrane Proteins
2026-09-04
Song and colleagues introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that redirects endoplasmic-reticulum-associated degradation toward transmembrane proteins. By combining a desonide-derived SYVN1-binding warhead with a PD-L1 ligand, the study achieves highly efficient PD-L1 depletion and stronger tumor suppression than a clinically used PD-L1 antibody in vivo.
-
Ginger Compounds and the Murine 5-HT3 Receptor
2026-09-03
This computational study mapped how gingerols, shogaols, and related compounds may interact with both orthosteric and proposed allosteric regions of the murine 5-HT3 receptor. Its results identify candidate receptor-contact residues and provide a structural hypothesis for dual competitive and non-competitive modulation relevant to chemotherapy-induced nausea and vomiting research.